SinoMab BioScience Limited (stock code: 3681.HK) is a Hong Kong based clinical-phase biopharmaceutical company focus on the development of novel and high-value recombinant therapeutic proteins for treating various life-threatening and debilitating diseases in human.

Biotechnology

Health Care

Life Sciences

SinoMab BioScience Ltd.

Shui On Leung

Zora Zhou

Shanchun Wang

Yuande Zhang

Guolin Xu

Ming Hon Yau

Jianping Hua

The Directors team at SinoMab BioScience Ltd. oversees critical functions including process development, quality control, production, marketing, and clinical and regulatory affairs. Each director ensures their department aligns with the company’s strategic objectives to advance the development and commercialization of innovative therapeutic proteins.

Directors

This department oversees the strategic direction and operational management of the organization.

Executive Leadership

The Leadership Team at SinoMab BioScience Ltd. is responsible for strategic decision-making, overseeing company operations, and driving growth. This team formulates and executes business strategies, manages financial planning, and oversees clinical and commercial activities to advance the development of novel therapeutic proteins.

Leadership Team

This department focuses on managing employee relations, recruitment, training, and organizational development.

SinoMab BioScience Ltd.

Org chart

Teams

Directors

Executive Leadership

Leadership Team

Human Resources

Offices

SinoMab BioScience Ltd.

Org chart

Teams

Directors

Executive Leadership

Leadership Team

Human Resources

Offices

Related companies